PRISM's Research Program
PRISM’s medicinal psychedelic research program seeks to develop evidence-based treatments that reduce suffering, enhance our understanding of disease mechanisms, and illuminate the study of consciousness itself. PRISM is globally connected and provides scientific expertise for clinical trial and technology development for medicinal psychedelics and consciousness research.
Psilocybin for End of Life Anxiety
From January 2018, PRISM has engaged with several stakeholders to initiate Australia’s first clinical trial of psilocybin-assisted psychotherapy, for anxiety and depression associated with terminal illness, at St Vincent’s Hospital Melbourne (CT-2018-CTN-04702-1).
Psilocybin for Depression
PRISM is also engaging with a research team based across several universities in Melbourne to initiate a clinical trial of psilocybin-assisted psychotherapy for Treatment-Resistant Depression (CT-2020-CTN-02260-1). This proof-of-concept study is in the latter stages of development and is planned to commence recruiting in January 2021.
MDMA for PTSD
As of September 2020, with the assistance of MAPS, PRISM has engaged with several stakeholders to initiate an Australian clinical trial of MDMA-assisted psychotherapy for Post-Traumatic Stress Disorder (PTSD) in collaboration with Edith Cowan University (CT-2020-CTN-02367-1).
5-MeO-DMT Research
PRISM’s medicinal psychedelic research program seeks to develop evidence-based treatments that reduce suffering, enhance our understanding of disease mechanisms, and illuminate the study of consciousness itself.
Mindfulness and Psychedelics
PRISM’s medicinal psychedelic research program seeks to develop evidence-based treatments that reduce suffering, enhance our understanding of disease mechanisms, and illuminate the study of consciousness itself.
Virtual Reality and Psychedelics
PRISM’s medicinal psychedelic research program seeks to develop evidence-based treatments that reduce suffering, enhance our understanding of disease mechanisms, and illuminate the study of consciousness itself.
Research for a better future
Current and future Australian research in this space will offer a crucial pathway for the provision of psychedelic-assisted therapy and to develop our understanding of consciousness itself. Notably, none of the current research into psychedelic-assisted treatments for mental illness in Australia is receiving government funding. With your support, our research paves the way for establishing evidence-informed psychedelic-assisted treatments
- hello@prism.org.au
Our Research
- Refer a Friend
- Updates
- Beta
MEDIA
- Article 1
- Article 2
- Article 3
About Us
- Mission
- Board and Team
- FAQ